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Abstract
The contrast mechanisms used for photoacoustic tomography (PAT) and fluorescence imaging
differ in subtle but significant ways. Design of contrast agents for each or both modalities requires
an understanding of the spectral characteristics as well as intra- and intermolecular interactions
that occur during formulation. We found that fluorescence quenching that occurs in the
formulation of near infrared (NIR) fluorescent dyes in nanoparticles results in enhanced contrast
for PAT. The ability of the new PAT method to utilize strongly absorbing chromophores for signal
generation allowed us to convert a highly fluorescent dye into an exceptionally high PA contrast
material. Spectroscopic characterization of the developed NIR dye-loaded perfluorocarbon-based
nanoparticles for combined fluorescence and PA imaging revealed distinct dye-dependent
photophysical behavior. We demonstrate that the enhanced contrast allows detection of regional
lymph nodes of rats in vivo with time-domain optical and photoacoustic imaging methods. The
results further show that the use of fluorescence lifetime (FLT) imaging, which is less dependent
on fluorescence intensity, provides a strategic approach to bridge the disparate contrast reporting
mechanisms of fluorescence and PA imaging methods.
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The nodal status of cancer is an important prognostic indicator for patients diagnosed with
melanoma,1 gynecological cancers,2 breast cancer,3 prostate cancer,4, 5 and other forms of
solid cancer. Metastatic spread of cancer cells occurs by the local invasion of adjacent tissue
and dissemination in the blood stream via the lymphatic system. Cancer cells that migrate
from the primary tumor may become lodged in the first lymph nodes draining the tumor
area. From that lymph node, the tumor cells migrate further into other lymph nodes and
blood stream, leading to wider spread of cancer. The closest lymph node that drains the
tumor area is called the sentinel lymph node (SLN). The SLN represents the most probable
first location of metastatic spread.3 Identification of the SLN is commonly performed in
clinics invasively using a colloid of radionuclide, such as 99mTc-labeled sulfur colloid6, 7
and/or injection of a dye, such as isosulfan blue or methylene blue8, 9 subcutaneously in
tissue surrounding the tumor location at the time of surgery. After initial clearance of the
probe, the nearby tissue is dissected and the location of the SLN is determined by a hand-
held scintillator as a hot spot or visually as a blue-stained tissue. The SLN is removed and
examined immediately by pathologist using standard intraoperative histological protocol.10–
12 If cancer cells are detected in SLN, surgical resection of the secondary lymph nodes
(radical resection) is performed to eradicate the tumor or prevent further metastasis.
Although these techniques have improved surgical practice and prevented further spread of
cancer, less invasive, highly sensitive, and more accurate localization of SLNs would further
improve patient care. Toward these goals, optical and hybrid methods for non-invasive SLN
detection have been developed, including fluorescence detection13, 14 and photoacoustic
(PA) imaging.15, 16
Fluorescent optical imaging is a well-known method for in vivo imaging and PA imaging is
a recent development that combines optical absorption contrast and fine ultrasonic
resolution. The advantage of the lymph node detection using PA imaging has been
demonstrated at depths more than 30 mm with resolution of 0.5 mm.15 Both, fluorescence
and PA imaging modalities utilize non-ionizing radiation and are therefore safer to patients
and medical staff relative to nuclear imaging methods.
To improve detection sensitivity, both fluorescence and PAT methods require contrast
reagents with high absorption coefficients in the NIR spectral region. Unfortunately,
commonly used blue dyes for SLN imaging absorb light below 700 nm, minimizing the
assessment of deep tissue since endogenous chromophores will rapidly attenuate light
penetration depth. In the first clinical trial, indocyanine green (ICG), a NIR fluorescent dye
emitting at ~ 800 nm, has been successfully evaluated as a new method for SLN biopsy in
breast cancer patients. The method facilitated noninvasive visualization of lymphatic vessels
and nodes as well as intraoperative identification of SLN.17 In contrast to fluorescence
methods that require probes with high fluorescence quantum efficiency, the probes for PAT
should be minimally emissive, enhancing conversion of absorbed light energy to heat and
subsequently to acoustic signal. Correspondingly, a combined modality requires a probe
with moderate fluorescence quantum yield to generate both emission and PA signal
simultaneously. To accomplish these goals, we explored the potential of starting with dyes
with high and low fluorescence yields. However, lymphatic vessels are permeable, allowing
the diffusion of small molecules back into tissue. Retaining molecular probes exclusively in
the lymphatic vessels, therefore, requires their conjugation to macromolecules or
formulation in nanoparticles. In addition to minimizing the spread of imaging probes beyond
SLN area, minimum retention of the probe at the site of injection is essential for accurate
localization of SLN.18 Currently used radioactive 99mTc-labeled sulfur colloid tends to
remain at the site of administration, slowly diffusing to a lymph node and therefore
producing a weak signal at SLN.19 Due to their small molecular size, blue dyes quickly pass
to secondary nodes, leading to difficulties in distinguishing SLN from other nodes. It has
been demonstrated that the solution to the problem lies in the application of hydrophilic
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nanoparticles, such as 99mTc-labeled liposomes with encapsulated dyes20 and other
nanoparticles,18 which can rapidly move through the lymphatic system to the SNL and are
retained there for a period long enough for surgery to be performed.
Herein, we investigated new perfluorocarbon (PFC) nanoparticles loaded with NIR dyes as
potential contrast reagents for SLN mapping in rats using PA and fluorescence contrast in
vivo (Figure 1). We previously demonstrated that receptor targeted PFC nanoparticles have
great potential for biomedical imaging and drug delivery applications21, 22 and can be
utilized for fluorescence imaging.23 Two different NIR fluorescent probes with disparate
fluorescence efficiency were used in the new PFC-based nanoparticle formulations to
provide fluorescence and PA contrast (Figure 1). Our results demonstrate the efficacy of
lymph node mapping with both modalities. More importantly, formulation of the NIR dye
with high fluorescence efficiency resulted in high PA signal due to intermolecular
fluorescence quenching effect.
RESULTS AND DISCUSSION
The detection of lymph nodes in vivo was previously demonstrated using the NIR
fluorescent agent, ICG24 but very high concentrations of the dye were needed. We
hypothesized that incorporation of NIR dyes in the PFC nanoparticles would improve PA
contrast at relatively smaller dye content. We explored PFC-based nanoparticles
incorporating two different NIR fluorescent dyes, PPCy-C8 and cypate-C18, as PA and
fluorescence imaging agents in this study. The contrast agents were first analyzed in vitro by
fluorescence lifetime (FLT) and PA measurements of dyes and nanoparticles in solution.
This characterization was followed by in vivo time-domain diffuse optical imaging and a
handheld PAT system to demonstrate potential applications of these novel contrast agents in
biomedical imaging.
While a variety of biocompatible emulsion-based nanoparticle systems have been developed
for optical imaging,25, 26 PFC-based nanoparticles are viable materials for non-invasive
detection. PFC is a biocompatible component that has a 3-day half-life in the body and is
completely eliminated through expired air via the lungs.21 We have developed methods for
decorating the surface of PFC nanoparticles with contrast and targeting agents by non-
covalent mechanisms, eliminating complex and low-yield synthetic steps.27 Thus we
developed NIR fluorescent PFC nanoparticles for optical and PA imaging by incorporating
NIR hydrophobic dyes, cypate-C1823 and PPCy-C828 (C18 and C8 indicate the number of
carbons in a hydrophobic chain) in the surface layer.
Spectroscopy
We explored the use of two NIR fluorescent dyes, PPCy-C8 and cypate-C18, as PA and
fluorescence imaging agents in this study. The synthesis and optical properties of these dyes
(absorption, emission and FLT) were reported previously.23, 28, 29 Both dyes possess high
molar absorptivity in NIR range >200,000 M−1 cm−1. Cypate-C18 has a moderate
fluorescence quantum yield and a relatively short FLT due to the flexible excited state
structure.23, 30 In contrast, PPCy-C8 with its highly rigid skeleton ensured by complexation
with disubstituted boron possesses high fluorescence quantum yield and much longer FLT
(Table 1). Both dyes have long hydrophobic tails for stable insertion into the phospholipid
layer on the surface of the nanoparticles. The dyes were successfully loaded in PFC
nanoparticles using a standard protocol (see Methods). All nanoparticles were uniformly
distributed with 220 +/− 11 nm mean diameter and less than 10% polydispersity as
determined by DLS. Upon incorporation in phospholipid shell, cypate-C18 retained the NIR
absorption and emission properties of the base molecule in 0.1 mol% to 0.3 mol%. The
detailed optical characterization of cypate-C18/PFC-nanoparticle was reported previously.23
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In contrast to cypate-C18, the PPCy-C8 fluorescence properties were altered upon
incorporation in nanoparticles. The absorption spectrum of the incorporated dye showed a
significant bathochromic shift from 754 nm in chloroform to 789 nm in the PFC
nanoparticle system in water (Table 1 and Figure 2A). The shift was accompanied by a
substantial decrease in molar absorptivity and fluorescence yield. Highly emissive properties
of the PPCy-C8 dye completely disappeared and the emission spectrum of the PPCy-C8/
PFC nanoparticles in water was very similar to the emission spectrum of the control PFC
nanoparticles with no dye (Figure 2B). The optical properties of the pure dyes Cypate-C18
and PPCy-C8 were determined in organic solvents because they are not soluble in water.
The drastic alteration in optical properties of PPCy-C8/PFC nanoparticles could be
attributed to a variety of factors, including chemical instability of the dye upon formulation.
To demonstrate stable incorporation, the dye was extracted with DCM and the optical
properties of the extract were recorded. Absorption and emission properties of the extract
were identical to that of the original dye (Supplemental Information, Fig. S1), clearly
demonstrating the structural integrity of the dye.
To further understand the underlying mechanism of changes in the optical properties, we
investigated the behavior of the dye in different solvents. The change in polarity from
chloroform to methanol caused a hypsochromic shift (Figure 3) while retaining strong
fluorescence. Thus, solvent polarity alone is not a compelling reason for spectral change.
However, we observed an alteration of the absorption spectra of PPCy-C8 in methanol over
time from a spectrum similar to PPCy-C8 in DCM to that of PPCy-C8/PFC in water (Figure
S2). This transformation suggests aggregation of the hydrophobic dye in a polar
environment. Similar changes in the absorption spectra with characteristic peaks at ~ 790 nm
and ~ 710 nm were also observed upon addition of water to a methanol solution of the dye
(Figure S3A and 3B), resulting in similar optical properties (Figure S3C) and indicating
similar mechanism of interaction in both solvent systems. Alterations of the absorption
spectra were accompanied by strong fluorescence quenching (Figure S3B). Based on these
results, we postulate that the change in absorption spectra and fluorescence quenching of the
dye incorporated in PFC nanoparticles were due to dye aggregation promoted by the
presence of water.
Addition of water (within the range of 5 – 10 volume%) on the time-scale of seconds gives
time-dependent changes that is ascribed to diffusion processes. Clear isosbestic points
(Figure S2) are good indicators that neither significant precipitation nor a variety of
differently large aggregates occurred. The observed effects can be explained with the
formation of dimers rather than higher aggregates with the monomeric units shifted
longitudinally and with an angle of about 30 to 60 degrees between the long axes,
representing the direction of the transition moment of the first electronic transition. These
interpretations are supported by the observed isosbestic points in the absorption spectra and
the occurrence of a short wavelength band in addition to the long wavelength band as shown
by the splitting of the 740 nm band into bands at 796 nm and 703 nm, respectively (Figure
2). Due to a relatively flat twisting (torsional) potential, a significant variation of the angle
between the monomer transition moments is expected at room temperature. Thus, around the
thermodynamically most preferred angle, a dynamic equilibrium of conformations with
larger or smaller angles produces an increase of the band half-widths under dimerization.
This mobility (low torsional rigidity) in the first excited electronic state should be an
efficient channel for the radiationless deactivation, resulting in loss of radiative transfer
fluorescence.
The increased loading of the dyes on PFC from 0.1 % to 0.3 % did not affect optical
properties of particles. Absorption properties of PPCy-C8/PFC were proportional to the
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loading change, making the nanoparticles greener in hue, with no increase in fluorescence
observed. Optical properties of the PPCy-C8/PFC helped to elucidate the structural features
of the nanoparticles. Specifically, the data suggest that the PPCy-C8 molecules in PPCy-C8/
PFC nanoconstruct are exposed to the solvent and therefore lie outside the shell. The
nanoconstruct is stable because the addition of bovine serum albumin solution to the
nanoparticle solutions did not changed the absorption and emission spectra. Addition of
albumin helps to identify if the dye is stably incorporated into a nanoparticle. Hydrophobic
dyes bind non-covalently to hydrophobic pockets of albumin and the binding effect can be
detected by a change in fluorescence intensity. Since no change in fluorescence intensity
was observed after the addition of albumin, the result unequivocally demonstrated that the
dye is stably incorporated within the PFC nanoparticles.
Upon loading in PFC nanoparticles, the dyes behaved differently with respect to quantum
yield of fluorescence and FLT. We hypothesized that lower fluorescence quantum yield of
dyes within the PFC nanoparticles would improve PA contrast due to higher heat yield,
which in turn would generate stronger ultrasound signal (thermal expansion).16 Non-
quenched nanoparticles are expected to produce higher fluorescence intensity but poor PA
signal. Enhanced fluorescence quenching was realized with PPCy-C8 upon formulation in
PFC nanoparticles, which retained relatively high absorption coefficient of the dye (~50,000
M−1 cm−1, see Table 1)
PA signals for free dyes and dye-loaded PFC nanoparticles were measured in solution using
a non-contact PA microscopy system.15 We confirmed that no PA signal (comparable to the
signal from background) was observed from PFC nanoparticles without loading any NIR
dye (Figure 4). PPCy-C8/PFC nanoparticles produced ~ 3.5 times greater PA amplitude than
comparable concentration (0.3 mol%) of cypate-C18/PFC and significantly higher signal (~9
times) than whole blood (Figure 4). We found that the free dyes did not produce sufficient
PA signal in vitro for further applications at equivalent dye concentrations for in vivo study
(data not shown).
Fluorescence quenching of PPCy-C8 in the PFC nanoparticles could be attributed to
exposure to aqueous medium or self-aggregation. Either way, the net result is the conversion
of absorbed light to heat, which improved the PA contrast through tissue thermal expansion.
The high PA signal of PPCy-C8/PFC nanoparticles relative to equivalent concentrations of
cypate-C18/PFC (Figure 4) is likely due to the difference in fluorescence properties of the
dyes after formulation rather than before. This assumption is corroborated by the intense
quenching present in the PPCy-C8/PFC nanoparticles as evidenced by lower fluorescence
yield and very short FLT. The cypate-C18/PFC nanoparticles are approximately 3 times
higher in fluorescence yield relative to PPCy-C8/PFC, in contrast to the yield of the free
dyes.
In Vivo Imaging
Before the injection of nanoparticles, the measured autofluorescence intensity in the lymph
node region was low and FLTs could not be calculated (Figure S5). After injection of PFC-
based nanoparticles subcutaneously in the forepaw of rats, fluorescence from the lymph
nodes was distinct at 1 hour and 24 hours after injection (Figure 7). Data comparison shows
that the measured fluorescence intensity for the lymph node region was not higher than 4 cps
(normalized by laser power and integration time) for the pre-injection scans, approximately
200 cps for PPCy-C8/PFC nanoparticles, and greater than 600 cps for cypate-C18/PFC. The
significant (P>0.01) increase in fluorescence for cypate-C18/PFC compared to PPCy-C8/
PFC particles was a direct consequence of highly quenched PPCy-C8 dye and possible
exposure to water.
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PAT was performed using the same rat model described above after subcutaneous injection
of contrast agent solutions in the front paws. Lymph nodes were detected by PAT at 3 hours
after injection, with excellent contrast at 24 hours after injection (Figure 5A, B, and C). The
corresponding B-scan images of lymph nodes clearly show the depth position of each lymph
node (Figure 5A1, B1, and C1). The average PA image contrasts of SLNs (n = 3 rats) at 3
and 24 hrs post-injection are 8.7 ± 1.3 and 12.3 ± 3.4, respectively (Figure 5D). Based on in
vivo spectroscopic PA analysis, which follows the trend of in vitro PA spectrum, we
confirmed that the measured PA amplitudes in vivo stemmed from lymph nodes containing
PPCy-C8/PFC nanoparticles (Figure 5E).
After imaging, the animals were euthanized and lymph nodes removed. PA and fluorescence
imaging were performed ex vivo to confirm the location of the signal to the lymph node
tissue and to assess the signal levels obtained in vivo relative to direct detection. The axillary
lymph node chain detected in vivo and confirmed by ex vivo imaging (Figure 6A). Obvious
fluorescence and PA signals were observed from three excised lymph nodes from the left
lymph node region (injection site), whereas both signals were too weak in one dissected
lymph node from the right region (no injection site). The PA image contrasts quantified
from in vivo and ex vivo PA imaging results agreed well, and the ex vivo fluorescence
imaging results confirmed this finding (Figure 6B), demonstrating the feasibility of using
these nanoparticles for PA and fluorescence mapping of lymph nodes.
Fluorescence imaging was also performed for detecting lymph nodes in the same animal
model. The fluorescence intensity and FLT maps for free dyes and dye-loaded PFC
nanoparticles are shown in Figure 7. The Cypate and PPCy-C8 were transported to the
regional lymph nodes faster than the nanoparticles and were imaged at 1 h and 4 h post-
injection FLT measurements shown in Figure 7 and obtained from decay curves (Figure 8)
demonstrated the quenched state of the PPCy-C8/PFC relative to cypate-C18/PFC
nanoparticles. The FLT of free PPCy-C8 in the lymph node was greater than 3 ns while the
PPCy-C8/PFC nanoparticles showed only 0.22 ns, close to the lowest minimum resolution
of the imager. The fluorescence intensity from the PPCy-C8 nanoparticles was also very low
relative to the free dye. In contrast, the mean FLT of cypate-C18/PFC was very close to that
of the free dye.
The FLTs were measured by single exponential fitting of the fluorescence decay curves
acquired as temporal point spread functions by the time-correlated single photon counting
(TCSPC) detector. Representative decay curves and fitted lifetimes are shown in Figure 8.
Both optical reporter systems provided contrast for fluorescence and PA detection, although
the PPCy-C8/PFC nanoparticles demonstrated enhanced PA contrast. A possible alternative
explanation of the drastic differences in the PA properties of the two dye-nanoparticle
formulations is based on the orientation of the dyes within material. In the case of C18/PFC
nanoparticles, both fluorescence quantum yield and lifetime measurements indicate that the
dyes were sequestered inside the hydrophobic core of the nanoparticle formulation. This
suggests that local heat generated by the system could be absorbed by the phospholipid outer
layer, thereby attenuating the resultant PA signal. In contrast, the dye in the PPCy-C8/PFC
formulation is possibly exposed to the outer aqueous phase, which results in direct
deposition of heat to the immediate surrounding and detectable as PA signal. The concerted
effect of many dye molecules per nanoparticles will further enhance the net PA signal. This
reasoning provides a strategy for optimizing dye formulation for either PA or fluorescence
contrast.
Interestingly, the PPCy-C8/PFC FLT remained low for the duration of the in vivo study,
indicating that leakage of the dye from the nanoparticles did not occur in detectable
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amounts. It is possible that the dye was released but remained in a quenched state due to
aggregation, though from previous reports, we would expect the lifetime to report on
diffusion of the hydrophobic dye.31
Relative to the small molecule fluorophores, the C18/PFC nanoparticles provided higher
SLN contrast due to more significant accumulation in the first lymph node. The small
molecule agents traveled faster to the SLN, progressing to second and third lymph nodes,
and draining into the circulatory system. Ex vivo fluorescence imaging of lymph nodes
showed differences in diffusion patterns between free dyes and nanoparticles. The free dyes
appear to have diffused along the lymph node chain, with fluorescence from cypate-C18
nearly equally distributed among the 3 lymph nodes. PPCy-C8 fluorescence was higher in
the second and third lymph nodes than the first, which corresponds to the in vivo imaging
results in Figure 6. The nanoparticles showed a more progressive diffusion pattern along the
chain, with the first lymph node having significantly higher fluorescence intensity than the
following two nodes (P < 0.05). Interestingly, the fluorescence intensity from the first lymph
nodes was generally higher for the nanoparticles than for the free dyes. These differences are
likely due to the faster transport of the free dyes through the lymph nodes relative to the
nanoparticles. Previous studies have shown that fast migration is not a benefit in SLN
detection but rather high accumulation in the LN of interest is more important.30 Thus,
these PFC nanoparticles are excellent contrast agents for non-invasive SLN detection and
subsequent biopsy or resection.
CONCLUSIONS
We have demonstrated contrast agents for identification of SLNs by both PA and
fluorescence detection systems. Despite similar behavior of fluorescent dyes, loading of
these dyes in PFC nanoparticles resulted in differential contrast for both optical and PA
imaging. Enhancement of PA signal by PPCy-C8/PFC nanoparticles resulted from
fluorescence quenching and possible exposure of the dye to aqueous environment. Since
there are multiple dye molecules per nanoparticle, this feature is expected to increase
thermal expansion of the immediate environment, leading to greater acoustic signal. These
results also show the benefit of nanomaterials for enhancement of contrast by increased
payload per particle. Although we have shown the advantage of a non-fluorescent system for
PA imaging, this does not preclude agents for simultaneous detection by both systems.
Fluorescence yield reduces PA contrast but does not abolish it. Development of fluorescent
and PA contrast agents must take into account both absorption and fluorescence yield in the
nanoparticle design. It is feasible to use PA for localization at early time points when the
dyes are in a quenched state and fluorescence detection may be used to monitor
longitudinally as PA contrast decreases. The different mechanisms of detection show the
strengths and weaknesses of PA and fluorescence imaging and the advantage of combining
the two modalities for noninvasive SLN mapping in cancer diagnosis. Lymph nodes were
detected by diffuse optical imaging and PA imaging, showing the capabilities for non-
invasive lymph node mapping.
METHODS
Materials
All reagents were spectroscopy grade or synthesized and purified to 95% or greater. DMSO,
chloroform, DCM, ethanol and methanol (Spectroscopy grade) were purchased from Sigma-
Aldrich (St. Louis, MO). The UV-vis absorption spectra of NPs were collected at room
temperature using Beckman 640 UV-visible spectrophotometer and quartz cuvette with 10
mm of light path. The fluorescence spectra of NPs were obtained at room temperature
Fluorolog III fluorescence spectrophotometer (Horiba. FLT was measured using TCSPS
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method as described previously. The FLTs were determined using excitation source
Nanoled® 700 nm, monitored emission 775 nm with bandpass 20 nm In all measurement a
three-exponential decay analysis was applied.
Synthesis
A hydrophobic derivative of cypate,32 cypate-C18,23 and diketopyrrolopyrrole cyanine,
PPCy-C833 were synthesized as previously described. PFC nanoparticles with both
hydrophobic dyes were formulated as previously described23 with the addition of NIR
fluorescent dyes for optical and PA imaging. Briefly, the nanoparticles were comprised of
20% (v/v) perfluorooctylbromide (PFOB), 2.0% (w/v) of a surfactant co-mixture, and 1.7%
(w/v) glycerin in distilled, deionized water. The surfactant co-mixture of nanoparticles
included 98 mole% lecithin (Avanti Polar Lipids, Inc., Alabaster, AL, USA), 0.1 mole% of
peptidomimetic ανβ3–integrin antagonist conjugated to PEG2000-phosphatidylethanolamine
(Kereos, Inc, St. Louis, MO, USA), 1.9 mole% phosphatidylethanolamine (Avanti Polar
Lipids, Inc., Alabaster, AL, USA). NIR dyes were substituted for lecithin on an equimolar
basis from 0.1 to 0.3 mol%.The surfactant components were combined with the PFOB,
water, and glycerin, the pH was adjusted to 7.5, and the mixture was emulsified
(Microfluidics, Newton, MA, USA) at 20,000 psi for 4 minutes. Nominal particle sizes and
polydispersity (220 +/− 11 nm with a polydispersity of 0.09) were measured by dynamic
light scattering (DLS, Brookhaven Instrument Corp., Holtsville, NY, USA).
Spectroscopy
The spectral properties of these formulations were characterized relative to control
nanoparticles without dye. The absorption and emission spectra of dye-loaded PFC
nanoparticles were subtracted from absorption and emission of control nanoparticles.
Solutions of free dye were formulated by dissolving dye in 20% DMSO in water at
concentration of 40 µM. NIR fluorescent nanoparticles were aliquoted (100 µL) into 1 mL
of PBS in a plastic cuvette and analyzed by absorption and fluorescence.
A stock solution of PPCy-C8 was prepared in DCM (26 mM). An aliquot 10 µL were
diluted 200 times with chloroform, DCM, ethanol and methanol in quartz cuvette and the
spectra (absorption, fluorescence) were recorded. FLT of the solutions was measured using
Nanoled 700 nm (Horiba) for excitation and 775 nm filter for emission. For aggregation
study, 70 µL of 0.5 mM of PPCy-C8 in DCM were added to a quartz cuvette filled with
1930 µL of methanol for a total concentration of 17 µM. Dye concentration and absorption
coefficients within PFC nanoparticles were determined by absorption spectroscopy for the
nanoparticles and after extraction with DMSO or DCM. Fluorescence quantum yield of the
nanoparticles was determined with reference to ICG, which has a quantum yield of 0.01 in
water.30
In vitro photoacoustic imaging
For measurement of PA signal from nanoparticles, Tygon® tubes were filled with aqueous
suspensions of PPCy-C8 nanoparticles, cypate-C18 PFC NPs or dye-free nanoparticles and
one tube filled with whole blood. The sealed tubes were embedded in a water bath.. PA
amplitude from nanoparticle solutions was measured and compared with blood for PA
contrast at 767 nm excitation using a PA imaging system and method as previously
described.34
Animal models
All animal studies were approved by the animal studies committee at Washington University
School of Medicine. Sprague-Dawley rats (Harlan, Indianapolis, IN) were anesthetized with
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ketamine and xylazine cocktail (87 mg/kg and 13 mg/kg, respectively, IP). Hair over the
axillary region was removed by gentle clipping and depilatory cream. Contrast agent
solutions (0.05 mL) were injected subcutaneously in the forepaw prior to imaging. For
fluorescence imaging, rats were injected on both sides while for PAT rats were injected in
the left forepaw only. Imaging was performed immediately after injection up to 4 hours after
injection and again at 24 hours after injection.
In vivo fluorescence imaging
Fluorescence imaging was performed with the eXplore Optix time-domain diffuse optical
imaging system (ART, Montreal, Canada). Animals were placed on the heated imaging
platform and adjusted for optimal height. Pre-injection scans (n=2) were acquired of the
axillary region with laser power of 500 µW and integration time of 0.3 s. Post-injection
scans were acquired at 1 and 4 hours after injection for free dyes and 1 and 24 hours after
injection for nanoparticles. Absorption and emission scans were performed sequentially for
all acquisitions. Integration time was kept at 0.3 s per step while laser power was adjusted to
achieve adequate signal strength for FLT measurement. Step size was 1 to 3 mm per step.
Fluorescence intensity and lifetime maps were constructed from acquired data by integration
or curve fitting of the fluorescence temporal point spread function (TPSF), respectively,
using Optiview software (ART, Montreal, Canada) as previously described.31 Fluorescence
intensity values are reported in counts per second and were normalized to laser power and
integration time. Mean fluorescence intensity and FLT values were determined by ROI
analysis.
In vivo photoacoustic imaging
After promising in vitro contrast with PPCy-C8 loaded nanoparticles, in vivo PA imaging
was performed. The three-dimensional PA imaging system is detailed in a previous
publication.15 A light wavelength of 767 nm was used for most of the experiments, but
optical wavelengths were tuned from 747 to 801 nm for spectroscopic analysis. For imaging
surrounding blood vessels, an optical wavelength of 570 nm was used. The light fluence on
the skin was 4 mJ/cm2, within the current ANSI limit. A single-element 5-MHz (for sentinel
lymph node imaging, V308, Panametrics-NDT) or 50-MHz (for surrounding vasculature
imaging, V214-BB-RM, Panametrics-NDT) ultrasound transducer was used as an ultrasonic
detector. Axial spatial resolutions of the 5-MHz and 50-MHz PA imaging systems are 144
and 15 µm, and lateral resolutions are 560 and 45 µm, respectively. The time of arrival of
PA waves provides one-dimensional depth-sensitive images (A-line). Mechanical raster
scanning in two lateral directions enables to form depth-resolved cross-sectional images (B-
scans) and three-dimensional images. Volumetric images were expressed via maximum
amplitude projection (MAP), which projected the maximum signal along each A-line onto
the corresponding two-dimensional plane. The imaging acquisition time for a 25 mm × 30
mm field of view was about 25 minutes. PPCy-C8 nanoparticle solutions (0.5 mg) were
administered by injection in the footpads of rats as described above. A series of PA images
were acquired to 3 h post-injection, and we obtained another PA image at 24 h post-
injection. The differential images of the SLNs before and after injection (i.e., images after
injection minus images before injection) were overlaid on the images of blood vessels.
Animals were euthanized after final imaging time points at 24 hours (nanoparticles) and 4
hours (small molecules) after injection. Ex vivo fluorescence imaging of lymph nodes was
performed with the Kodak IS4000MM planar reflectance imaging system (Carestream
Health, New Haven, CT) with 755 nm excitation and 830 nm emission detection. Ex vivo
PAT was performed by embedding dissected lymph nodes in gelatin phantom and imaging.
For comparison of fluorescence and PAT contrast, gelatin-embedded lymph nodes were also
imaged with planar reflectance imaging system.
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Figure 1.
Structure of NIR fluorescent dyes cypate-C18 and diketopyrrolopyrrole cyanine (PPCy-C8)
and schematic of dye-loaded PFC nanoparticles. Perfluorocarbon core is encapsulated in
amphiphilic phospholipid layer (blue) containing hydrophobic dyes (green).
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Figure 2.
Absorption (A) and emission (B) of PPCy-C8/PFC nanoparticles in water and after
extraction of the dye from liposome with dichloromethane (DCM). Ex. 720 nm. Absorption
spectrum of PPCy-C8/PFC was corrected by the absorption of PFC with no dye.
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Figure 3.
Shift in absorption (A) and emission (B) of PPCy-C8 in different solvents (conc. 1.3 µM in
all solutions, ex. 720 nm)
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Figure 4.
Comparison of PPCy-C8/PFC and cypate-C18/PFC nanoparticle PA image contrast relative
to whole blood at an optical wavelength of 767 nm. The concentration of PPCy-C8 varied
from 0.1 mol% to 0.3 mol%. BG: background
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Figure 5.
Noninvasive PA MAP images of the left axillary region of a rat. (A) Control image acquired
before PPCy-C8/PFC nanoparticles. (B) PA image at 3 hr post-injection. (C) PA image at 24
hr post-injection. (A1), (B1), and (C1) Corresponding B-scan images along the cuts A1, B1,
and C1, in Figs. 5A, 5B, and 5C. (D) Average PA image contrast from SLNs at 3 and 24 hrs
post-injection (n=3). Error bars represent SD. (E) Comparison of spectroscopic PA
amplitudes between in vitro and in vivo results. BV: blood vessels; LN: lymph node; SLN:
sentinel lymph node; BG: background. Red color: blood vessels; green color: lymph nodes.
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Figure 6.
(A) Brightfield, PA, and FL images of ex vivo lymph nodes 24 hours after intradermal
administration of PPCy-C8/PFC nanoparticles into the left forepaw of the rat. (B)
Comparison of PA image contrasts quantified from in vivo and ex vivo results, and
fluorescence intensity from ex vivo results. PA: photoacoustic; FL: fluorescence; BG:
background
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Figure 7.
Fluorescence intensity and lifetime maps of rats at indicated times after subcutaneous
injection of contrast agents in the forepaw. The intensity maps indicate the relative
concentration of contrast agents within the axillary area at given times while the FLT maps
show the differences in contrast agents used. The FLTs of cypate and cypate-C18/PFC
nanoparticles are almost equal while the free PPCy-C8 has much higher FLT relative to the
PPCy-C8/PFC nanoparticles.
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Figure 8.
Normalized fluorescence decay curves with linear regression lines and calculated FLTs of
free dyes and NIR fluorescent nanoparticles in the axillary lymph nodes measured by TD-
DOI in living rats.
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